investing

Profit from Following Activist Investors

When investors like Carl Icahn and Bill Ackman turn the heat on management, shareholders stand to benefit.

One way to make money is to mimic Wall Street’s activists—investors who, in an effort to unlock a firm’s value, buy a big stake and then pressure top execs to take steps to boost the share price. By persuading the bosses, other shareholders or both of the wisdom of their approach, activists can force a company to cut costs, split in two, unload a lagging unit or sell the entire business.

Although the strategy requires patience, I’m a believer in its effectiveness. My portfolio holds major positions in four stocks—Apple (symbol AAPL, $127), Darden Restaurants (DRI, $63), Howard Hughes (HHC, $145) and Juniper Networks (JNPR, $24)—partly because of activist support. (Prices are as of March 6.)

You may not like activists such as Carl Icahn and Bill Ackman, but, by capitalism’s standards, they are the good guys. A 2013 study by Columbia, Duke and Harvard found that companies targeted by an activist actually performed better—-as businesses, not just as stocks—-five years after the activist’s campaign began.

Finding out what the big guys are doing is easy. When a person or a group acquires more than 5% of a publicly traded company, the buyer must file a Form 13D with the Securities and Exchange Commission. After an activist files a 13D, the stock he or she has purchased rallies a quick 6%, on average. But the stock often relinquishes much or all of the gain, and a waiting game begins.

Few know more about 13D filings than Ken Squire. He publishes the 13D Monitor, an advisory service that tracks the moves of activists, and he manages the 13D Activist Fund (DDDAX), a mutual fund that beat the stock market in each of its first three full years of existence, starting in 2012.

When Squire started his service, activists were often derided as quick-buck artists who cared only about their own wallets. No longer. “The trend is for companies to work with activists,” Squire says, “because advisers tell them activists are getting so much more support from other shareholders.”

That is good news for me (and for you) because it means activists with a persuasive argument have a much greater chance than in the past of having their agenda adopted. Accordingly, says Squire, you should buy the stock of a targeted company not when an activist’s position is disclosed but when he or she wins a seat or two on a company’s board of directors. By joining the board, an activist can help boost the stock without setting off any fireworks. Squire notes that shares of Valeant Pharmaceuticals (VRX) have climbed 11-fold since Jeff Ubben’s ValueAct Capital first got a seat on the board in 2007. (I own Valeant, too.)

I’m hoping for something similar at Darden Restaurants, which owns Olive Garden and other restaurant chains. Jeff Smith, of hedge fund Starboard Value, became Darden’s chairman last October and was able to have his entire slate elected to the board. “With Smith on board,” Squire says, “you know that anything done will be value-enhancing to shareholders.”

Not foolproof. Sometimes activists goof, as Pershing Square’s Ackman did when he installed a new CEO at J.C. Penney. But activists, unlike entrenched executives, almost never take an action that enriches themselves at the expense of other shareholders.

Squire’s three favorite activist situations today are Darden; Juniper Networks, where Elliott Management has helped to elect four independent directors; and Zoetis (ZTS), the animal health care giant where Ackman just won two board seats.

A mimicking strategy doesn’t win overnight. Juniper was $22 when Elliott got involved early in 2014. The stock has since climbed all of two bucks. But patience has always been a core value for value investors, so why should things be any different when hitching a ride with an activist?

Most Popular

‘I Can’t Retire – I Need Health Insurance’
health insurance

‘I Can’t Retire – I Need Health Insurance’

Health insurance is seen as a huge hurdle for early retirees, but the answer to finding affordable coverage could be simpler than you think.
August 7, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The 25 Cheapest U.S. Cities to Live In
places to live

The 25 Cheapest U.S. Cities to Live In

Take a look at our list of American cities with the lowest costs of living. Is one of the cheapest cities in the U.S. right for you?
August 7, 2022

Recommended

Has Inflation Peaked? Here's What the Experts Are Saying
investing

Has Inflation Peaked? Here's What the Experts Are Saying

Inflation decelerated by more than expected in July, but that doesn't mean our era of fast-rising prices – or Fed rate hikes – is over.
August 10, 2022
IRA Bill a Blessing in Disguise for Drug Stocks?
investing

IRA Bill a Blessing in Disguise for Drug Stocks?

Coming limits on drug pricing may not be bad news for drug makers after all.
August 10, 2022
How to Beef Up Your Portfolio Against Inflation
investing

How to Beef Up Your Portfolio Against Inflation

These sectors are better positioned to benefit from rising prices.
August 10, 2022
10 Facts You Must Know About Recessions
Markets

10 Facts You Must Know About Recessions

Fears of an economic downturn are once again on the rise, but what is a recession, exactly? We tackle this and other questions here.
August 7, 2022